Impact of Fever Prevention in Brain Injured Patients (INTREPID)

Is this Study for You?

Let's Get Started!


Patients randomized to the fever prevention group will have ArcticGel Pads placed on their body. These will be connected to the Arctic Sun System. The system will be programmed to keep the patient's body temperature at 98.6. Treatment will last for 14 days or until ready to be discharged from the ICU. Standard of care patients will receive standard medical care as prescribed by the medical team.




Adult, primary diagnosis of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage

Type of Study



University of Colorado Hospital

Principal Investigator
Photograph of Luis Cava Prado,  MD

Luis Cava Prado, MD

Study ID

Protocol Number: 18-0548

More information available at NCT02996266

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers